S&T BANK/PA - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 5 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
S&T BANK/PA ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,107
+17.9%
334,252
-3.7%
1.76%
+26.2%
Q2 2023$7,727
+1.7%
347,260
-1.0%
1.39%
+1.4%
Q1 2023$7,601
+8.1%
350,924
+1.3%
1.37%
+5.7%
Q4 2022$7,033
-99.9%
346,306
-0.9%
1.30%
-25.0%
Q3 2022$8,960,000
-24.4%
349,456
-29.9%
1.73%
-16.9%
Q2 2022$11,855,000
+3.5%
498,539
-2.0%
2.08%
+20.5%
Q1 2022$11,452,000
+12.6%
508,546
-1.0%
1.73%
+16.4%
Q4 2021$10,174,000
+6.5%
513,827
+5.9%
1.48%
+0.3%
Q3 2021$9,552,000
-12.0%
485,376
-1.6%
1.48%
-12.2%
Q2 2021$10,855,000
-8.3%
493,414
-0.8%
1.68%
-12.5%
Q1 2021$11,837,000
-16.6%
497,525
-8.3%
1.93%
-24.5%
Q4 2020$14,196,000
+41.8%
542,677
-5.7%
2.55%
+11.5%
Q3 2020$10,012,000
+6.0%
575,277
+2.5%
2.29%
+6.3%
Q2 2020$9,442,000
+34.9%
561,312
-4.6%
2.15%
+11.6%
Q1 2020$6,999,000
-4.5%
588,620
-2.8%
1.93%
+28.4%
Q4 2019$7,327,000
-17.3%
605,567
-3.1%
1.50%
-21.6%
Q3 2019$8,859,000
+26.1%
625,078
-0.8%
1.92%
+24.5%
Q2 2019$7,023,000
-2.5%
629,826
+2.6%
1.54%
-5.1%
Q1 2019$7,205,000
-14.1%
613,740
-2.2%
1.62%
-16.6%
Q4 2018$8,387,000
-16.5%
627,728
-12.3%
1.94%
+3.7%
Q3 2018$10,039,000
+60.5%
716,023
+80.0%
1.88%
+58.5%
Q2 2018$6,253,000
-10.8%
397,769
-6.7%
1.18%
-5.3%
Q1 2018$7,012,000426,2571.25%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders